The pharmacogenetics of antimalarial agents are poorly known, although the use of pharmacogenetics could be critical in optimizing treatment. (artesunate-mefloquine and dihydroartemisinin-piperaquine) also to assess whether hereditary polymorphisms impact the pharmacokinetic profile of Serves, furthermore to nongenetic elements. Strategies and Components Research areas, style, and populations. This research was element of an medication efficacy research… Continue reading The pharmacogenetics of antimalarial agents are poorly known, although the use